Moderna Aktie

146,26USD 2,88USD 2,01%
Moderna hier für 0 Euro handeln mit finanzen.net zero
WKN DE: A2N9D9 / ISIN: US60770K1079
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 86,30
Baillie Gifford & Co. 11,07
Vanguard Small Cap Index Fund 1,74
Lone Pine Capital LLC 0,82

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020 2021
Personal am Ende des Jahres 0 760 830 1 300 2 700
Umsatz pro Mitarbeiter in Mio. EUR 0,00 0,18 0,07 0,62 6,82

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020 2021
Summe Umlaufvermögen 783 1 563 1 129 6 298 16 071
Summe Anlagevermögen 641 1 574 1 311 2 799 15 061
Summe Aktiva 1 084 1 962 1 589 7 337 24 869

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020 2021
Gesamtverschuldung/ -verbindlichkeiten 16 44 136 238 916
Summe Fremdkapital 459 432 415 4 775 10 724
Summe Eigenkapital 625 1 530 1 175 2 561 14 145
Summe Passiva 1 084 1 962 1 589 7 337 24 869

Adresse

200 Technology Square, 02139 Cambridge
Telefon +1 (617) 714-6500
Internet http://www.modernatx.com

Management

Charbel Haber
Senior Vice President-Regulatory Affairs
David W. Meline
Chief Financial Officer
Elizabeth E. Tallett
Independent Director
Elizabeth G. Nabel
Independent Director
Francois Nader
Independent Non-Executive Director
Jacqueline Miller
Senior VP-Infectious Disease Development
John Lepore
Senior Vice President-Government Engagement
Jonathan Hoggatt
Director-Hematology
José M. Vega
Chief Safety Officer
Juan Andres
Chief Technical Operations & Quality Officer
Kate Cronin
Chief Brand Officer
Lavina A. Talukdar
Senior Vice President & Head-Investor Relations
Marcello Damiani
Chief Digital & Operational Excellence Officer
Melanie Ivarsson
Chief Development Officer
Michael Mullette
Managing Director-Canada
Noubar B. Afeyan
Chairman
Patrick Norman Bergstedt
Senior Vice President-Commercial Vaccines
Paul Burton
Chief Medical Officer
Paul L. Sagan
Independent Non-Executive Director
Paula Hammond
Scientific Advisory Board
Raymond C. Jordan
Chief Corporate Affairs Officer
Robert S. Langer
Independent Non-Executive Director
Sandra J. Horning
Independent Director
Shannon Thyme Klinger
Secretary & Chief Legal Officer
Stephen A. Berenson
Independent Non-Executive Director
Stephen Hoge
President
Stéphane Bancel
Chief Executive Officer & Director
Tracey Franklin
Chief Human Resources Officer